IPP Bureau
Krsnaa Diagnostics completes Tripura project
By IPP Bureau - February 04, 2023
Company has provided Image Transmission and Reporting of Radiology Images and Selective Radiology Services (X-ray Tele Radiology Services) across all districts in the state of Tripura during the month of June, 2022 and operationalized its services at all the allocated places as on date.
Ritesh Jain appointed CFO of Krebs Biochemicals and Industries
By IPP Bureau - February 04, 2023
He is a Chartered Accountant with more than 19 years of extensive experience
.jpg "Lupin launches Aptivate Champion Run for Kids")
Lupin launches Aptivate Champion Run for Kids
By IPP Bureau - February 04, 2023
Through this important initiative, Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in the Aptivate Champion Run
AstraZeneca India expands ‘Ganga Godavari Cancer Screening’ initiative
By IPP Bureau - February 04, 2023
The initiative launched in 2019 has touched over 10,000 lives with 500+ screening camps and aims to double its reach in the next 2 years
Mumbai FC Football players encourage cancer survivors at Nanavati Max Super Speciality Hospital
By IPP Bureau - February 04, 2023
The players and management of Mumbai City FC presented patients with exclusive gifts, symbolizing support and appreciation for their fight against cancer
GMM Pfaudler posts Q3 FY23 consolidated profit at Rs. 18.67 Cr
By IPP Bureau - February 03, 2023
The company has reported total income of Rs. 781.40 crores during the period ended December 31, 2022
Theramex select CARA Life Sciences Platform to consolidate and digitise Regulatory Processes
By IPP Bureau - February 03, 2023
Theramex were searching for a platform to digitise the manual processes across their R&D landscape
Apollo Hospitals partners with MediSage
By IPP Bureau - February 03, 2023
Experts’ conclave to pave holistic approach to cancer management
Dabur India consolidated Q3FY23 PAT lower at Rs. 475.94 Cr
By IPP Bureau - February 03, 2023
The company has posted net profit of Rs. 475.94 crores for the period ended December 31, 2022
Jubilant Ingrevia posts Q3FY23 consolidated PAT at Rs. 91.53 Cr
By IPP Bureau - February 02, 2023
The company has reported total income of Rs. 1165.31 crores during the period ended December 31, 2022
Hester Biosciences Q3 FY23 consolidated net profit up at Rs. 11.18 Cr
By IPP Bureau - February 02, 2023
The company has reported total income of Rs. 79.33 crores during the period ended December 31, 2022
Jubilant’s Radiopharma business receives NDA approval for Technetium Mertiatide Injection
By IPP Bureau - February 02, 2023
The Tc 99m Mertiatide Injection is used in the diagnosis of congenital and acquired renal abnormalities
Balaxi Pharmaceuticals revenue up 40.3%
By IPP Bureau - February 02, 2023
During the quarter, foreign exchange fluctuations had an impact of Rs. 4.56 crore Q3 FY23 Profit After Tax after considering exchange rate fluctuations stood at Rs. 8.2 crore
Budget 2023-24: Industry welcomes focus on medical research and pharma innovation
By IPP Bureau - February 02, 2023
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
Lupin receives tentative approval from USFDA for DETAF tablets
By IPP Bureau - February 01, 2023
DETAF would be a welcome new addition in the management of HIV infections and will be available for supplies to low- and middle-income countries
